Skip to main content
Y-Biologics, Inc logo

Y-Biologics, Inc — Investor Relations & Filings

Ticker · 338840 ISIN · KR7338840002 KO Professional, scientific and technical activities
Filings indexed 117 across all filing types
Latest filing 2025-07-30 Capital/Financing Update
Country KR South Korea
Listing KO 338840

About Y-Biologics, Inc

https://ybiologics.com/en/

Y-Biologics, Inc. is a biotechnology company specializing in the discovery and development of novel antibody-based therapeutics. The company's primary focus is on immuno-oncology, where it develops next-generation multispecific antibodies for the treatment of cancer. Y-Biologics leverages its proprietary human antibody discovery platform to advance its internal pipeline and support collaborations through technology transfers and joint development partnerships.

Recent filings

Filing Released Lang Actions
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). This type of filing is a standard regulatory disclosure in the Korean market for capital raising activities, which falls under the 'Capital/Financing Update' category.
2025-07-30 Korean
주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for Y-Biologics, detailing the date, time, location, and agenda items. This type of document is a standard proxy solicitation or meeting notice sent to shareholders to inform them of an upcoming vote. Given the specific category list, 'PSI' (Proxy Solicitation & Information Statement) is the most accurate classification for a notice of a shareholder meeting.
2025-07-30 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a formal notice from Y-Biologics regarding the setting of a record date for an upcoming Extraordinary General Meeting (EGM). It specifies the record date (2025-08-14) and the purpose (determining shareholders for the EGM). This type of regulatory disclosure regarding shareholder meetings and record dates is standard for general regulatory announcements in the Korean market, fitting the RNS category as it does not represent a full proxy statement or a specific voting result.
2025-07-30 Korean
투자판단관련주요경영사항 ([국책과제 선정] 글로벌 시장 진출형 다중항체의 품질 맞춤형 생산공정 기술 개발)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure from Y-Biologics regarding the selection of a government-funded R&D project. It details the project title, research partners, duration, budget, and development goals. This type of disclosure, which informs investors of significant business developments or material events that do not fall into specific categories like M&A or dividends, is classified as a general regulatory filing.
2025-07-15 Korean
투자판단관련주요경영사항 ([국책과제 선정] 면역함암 항체의약품의 저항성 및 불응성 한계 극복을 위한 이중항체-사이토카인 접합체의 제조기술 개발)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Y-Biologics regarding a 'major management matter' (투자판단 관련 주요경영사항), specifically the selection for a government-funded R&D project. It details the project scope, research partners, duration, and budget. Since this is a specific regulatory disclosure of a material event that does not fit into categories like financial reports, dividends, or share transactions, it falls under the general regulatory filing category.
2025-07-01 Korean
전환주식의전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Y-Biologics regarding the exercise of conversion rights for convertible preferred shares into common shares. This involves a change in the company's capital structure (issuance of new common shares and reduction of preferred shares). According to the filing definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2025-05-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.